Louisiana State Employees Retirement System Acquires 11,300 Shares of Enovis Corporation (NYSE:ENOV)

Louisiana State Employees Retirement System lifted its stake in Enovis Corporation (NYSE:ENOV - Free Report) by 72.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,800 shares of the company's stock after buying an additional 11,300 shares during the period. Louisiana State Employees Retirement System's holdings in Enovis were worth $1,024,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in ENOV. Farther Finance Advisors LLC lifted its position in Enovis by 266.7% during the 1st quarter. Farther Finance Advisors LLC now owns 737 shares of the company's stock worth $27,000 after acquiring an additional 536 shares during the period. Aster Capital Management DIFC Ltd acquired a new stake in shares of Enovis in the 4th quarter worth approximately $29,000. Quadrant Capital Group LLC increased its position in shares of Enovis by 53.0% in the fourth quarter. Quadrant Capital Group LLC now owns 690 shares of the company's stock valued at $30,000 after buying an additional 239 shares in the last quarter. Quarry LP increased its holdings in Enovis by 506.1% during the 4th quarter. Quarry LP now owns 897 shares of the company's stock valued at $39,000 after acquiring an additional 749 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in Enovis by 144.8% during the 1st quarter. GAMMA Investing LLC now owns 1,170 shares of the company's stock valued at $45,000 after buying an additional 692 shares during the last quarter. Institutional investors and hedge funds own 98.45% of the company's stock.

Enovis Price Performance

Shares of NYSE:ENOV traded up $0.96 during trading on Tuesday, reaching $27.26. The company had a trading volume of 1,658,255 shares, compared to its average volume of 941,615. The firm's fifty day moving average is $32.40 and its 200 day moving average is $36.98. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.32 and a current ratio of 2.55. The firm has a market capitalization of $1.56 billion, a PE ratio of -1.95 and a beta of 1.70. Enovis Corporation has a twelve month low of $25.93 and a twelve month high of $49.83.

Enovis (NYSE:ENOV - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.74 by $0.07. Enovis had a positive return on equity of 5.99% and a negative net margin of 37.65%. The business had revenue of $558.83 million during the quarter, compared to the consensus estimate of $558.80 million. During the same period in the prior year, the business posted $0.50 earnings per share. Enovis's revenue was up 8.2% compared to the same quarter last year. On average, equities analysts forecast that Enovis Corporation will post 2.79 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have weighed in on ENOV. Evercore ISI reduced their price target on shares of Enovis from $48.00 to $46.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. JMP Securities dropped their price objective on shares of Enovis from $62.00 to $55.00 and set a "market outperform" rating on the stock in a research note on Friday, May 9th. Needham & Company LLC decreased their target price on shares of Enovis from $64.00 to $57.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Finally, Canaccord Genuity Group dropped their price target on shares of Enovis from $75.00 to $70.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $55.60.

Enovis Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.